Accueil   Diary - News   All news 26 European healthcare SMEs participate in a trade mission to Japan with bioXclusters Plus

26 European healthcare SMEs participate in a trade mission to Japan with bioXclusters Plus


The European Strategic Cluster Partnership on Personalized Healthcare, bioXclusters Plus - gathering Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont) and Lyonbiopole (Auvergne Rhone-Alpes) – organizes in collaboration with the EU Japan Centre a mission to Japan from Oct 10th to 14th 2016. The mission will take place in Osaka and Yokohama.



The delegation is composed by the 4 clusters’ representatives along with 26 SMEs* from the bioXclusters Plus' regions.


An agenda dedicated to SMEs and networking


The company delegation will benefit, on October 10th, from one training day dedicated to acquiring knowledge about the Japanese healthcare sector, organized in cooperation with the EU-Japan Centre. On October 11th, the delegation will participate in a dedicated “European Biotech & Pharma Partnering Conference” organized by bioXclusters Plus at the Senri-Life Science Center in Osaka, with the support of Osaka Bio Headquarters and the EU Japan Centre.


On this occasion, more than 150 participants from Japanese and European life sciences and healthcare companies will have the opportunity to network and meet in face-to-face meetings. Around 330 meetings are planned. This unique event has been built up thanks to a growing collaboration between the bioXclusters Plus’ partners and its Osaka counterparts.


In the last three days, the full delegation will join the Bio Japan Conference in Yokohama, where European companies will have new opportunities to meet with other Japanese players. The Bio Japan convention is one of the largest event on biotechnologies in Asia, offering multiple business opportunities for companies with around 800 companies participating each year. Moreover, bioXclusters Plus will introduce the initiative to Japan during the Bio Cluster summit at Bio Japan, organized by the Japan Bioindustry Association (JBA) on October 13th.



 Read the press release